Picture of Marksans Pharma logo

MARKSANS Marksans Pharma Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+36.04%
3m+70.97%
6m+76.74%
1yr+118.32%
Volume Change (%)
10d/3m+64.94%
Price vs... (%)
52w High-1.01%
50d MA+35.03%
200d MA+69.44%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)31.16
PEG Ratio (f)1.76
EPS Growth (f)21.54%
Dividend Yield (f)0.56%
Valuation (ttm)IndustryMarket
Price to Book Value6.45
Price to Tang. Book6.79
Price to Free Cashflow617.08
Price to Sales5.87
EV to EBITDA26.53

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital17.63%
Return on Equity17.52%
Operating Margin17.81%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueIN₹m11,342.0913,761.8214,908.3918,521.3921,774.0726,27830,77016.84%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+53+98.11-23.32+42.28+12.09+16.8+26.19n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Marksans Pharma EPS forecast chart

Profile Summary

Marksans Pharma Limited is an India-based company, which is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets. The Company's product portfolio spreads various therapeutic segments of cardiovascular system (CVS), central nervous system (CNS), antidiabetic, pain management, cough and cold, gastroenterological, and anti-allergies. Its product portfolio includes tablets (plain, enteric-coated and film-coated), hard capsules, soft gelatin capsules, oral liquids and ointments. Its consumer self-care products (over the counter) include pain management, upper respiratory, digestive health, vitamins minerals and supplements (VMS) and skin care products. The Company's prescription - Rx therapeutic segments include CVS, CNS, oncology, anti-diabetics and anti-biotic. Its end consumers include retail chains, pharmacy stores, hospitals and institutions. It has manufacturing facilities in India, the United Kingdom and the United States.

Directors

Last Annual
March 31st, 2024
Last Interim
June 30th, 2024
Incorporated
April 16th, 1992
Public Since
April 3rd, 2002
No. of Shareholders
254,699
No. of Employees
2,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
453,163,746

MARKSANS Share Price Performance

Upcoming Events for MARKSANS

Dividend For MARK.NS - 0.6000 INR

Marksans Pharma Ltd Annual Shareholders Meeting

Q2 2025 Marksans Pharma Ltd Earnings Release

Q3 2025 Marksans Pharma Ltd Earnings Release

Similar to MARKSANS

Picture of Aarey Drugs and Pharmaceuticals logo

Aarey Drugs and Pharmaceuticals

in flag iconNational Stock Exchange of India

Picture of Aarti Drugs logo

Aarti Drugs

in flag iconNational Stock Exchange of India

Picture of Aarti Pharmalabs logo

Aarti Pharmalabs

in flag iconNational Stock Exchange of India

Picture of Abbott India logo

Abbott India

in flag iconNational Stock Exchange of India

Picture of Accent Microcell logo

Accent Microcell

in flag iconNational Stock Exchange of India

FAQ